BACKGROUND: Hepatitis C virus (HCV) can be transmitted vertically from mother to infant, either late in pregnancy or at delivery. AIMS: To determine the outcome of infants born to HCV infected women, to characterise epidemiology and to design an appropriate infant monitoring schedule. METHODS: Three hundred and fourteen infants, born to 296 HCV positive women between 1994 and 1999 were monitored for a median of 18 months (range 1-52). RESULTS: Forty per cent of infants were small for age and 46% had neonatal abstinence syndrome (NAS). Of 173 infants of defined status, 11 were infected (vertical transmission rate [VTR] 6.4%, 95% CI 2.8-10). Infected infants were diagnosed at a median of three months (range 0.5-10). Liver transaminases elevation was documented in 8% of uninfected infants. A negative HCV PCR test before one month of age did not exclude infection but all infected patients had detectable HCV RNA when next tested (range 2-10 months). CONCLUSIONS: 94% of infants born to HCV antibody positive women are not HIV infected. Liver transaminase elevation in exposed infants is not always indicative of infection. A minimum monitoring schedule of testing (PCR and antibody) at six to eight weeks, six and 18 months allows early diagnosis while detecting late seroconversions.
BACKGROUND:Hepatitis C virus (HCV) can be transmitted vertically from mother to infant, either late in pregnancy or at delivery. AIMS: To determine the outcome of infants born to HCV infected women, to characterise epidemiology and to design an appropriate infant monitoring schedule. METHODS: Three hundred and fourteen infants, born to 296 HCV positive women between 1994 and 1999 were monitored for a median of 18 months (range 1-52). RESULTS: Forty per cent of infants were small for age and 46% had neonatal abstinence syndrome (NAS). Of 173 infants of defined status, 11 were infected (vertical transmission rate [VTR] 6.4%, 95% CI 2.8-10). Infected infants were diagnosed at a median of three months (range 0.5-10). Liver transaminases elevation was documented in 8% of uninfected infants. A negative HCV PCR test before one month of age did not exclude infection but all infected patients had detectable HCV RNA when next tested (range 2-10 months). CONCLUSIONS: 94% of infants born to HCV antibody positive women are not HIV infected. Liver transaminase elevation in exposed infants is not always indicative of infection. A minimum monitoring schedule of testing (PCR and antibody) at six to eight weeks, six and 18 months allows early diagnosis while detecting late seroconversions.
Authors: C M Healy; M T Cafferkey; A Conroy; S Dooley; W W Hall; M Beckett; R Mackey; T A Clarke; M J White; W A Gorman; K M Butler Journal: Ir J Med Sci Date: 2000 Jul-Sep Impact factor: 1.568
Authors: C Mazza; A Ravaggi; A Rodella; D Padula; M Duse; M Lomini; M Puoti; A Rossini; E Cariani Journal: J Med Virol Date: 1998-01 Impact factor: 2.327
Authors: M O Granovsky; H L Minkoff; B H Tess; D Waters; A Hatzakis; D E Devoid; S H Landesman; A Rubinstein; A M Di Bisceglie; J J Goedert Journal: Pediatrics Date: 1998-08 Impact factor: 7.124
Authors: V Papaevangelou; H Pollack; G Rochford; R Kokka; Z Hou; D Chernoff; B Hanna; K Krasinski; W Borkowsky Journal: J Infect Dis Date: 1998-10 Impact factor: 5.226
Authors: D T Dunn; C D Brandt; A Krivine; S A Cassol; P Roques; W Borkowsky; A De Rossi; E Denamur; A Ehrnst; C Loveday Journal: AIDS Date: 1995-09 Impact factor: 4.177
Authors: F Davidson; P Simmonds; J C Ferguson; L M Jarvis; B C Dow; E A Follett; C R Seed; T Krusius; C Lin; G A Medgyesi Journal: J Gen Virol Date: 1995-05 Impact factor: 3.891
Authors: A R Zanetti; E Tanzi; S Paccagnini; N Principi; G Pizzocolo; M L Caccamo; E D'Amico; G Cambiè; L Vecchi Journal: Lancet Date: 1995-02-04 Impact factor: 79.321
Authors: H Ohto; S Terazawa; N Sasaki; N Sasaki; K Hino; C Ishiwata; M Kako; N Ujiie; C Endo; A Matsui Journal: N Engl J Med Date: 1994-03-17 Impact factor: 91.245